Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication
Background/Aims The treatment options for Helicobacter pylori (H. pylori) infection are in a state of flux: traditional triple therapies have started to fail, and new treatments are unable to achieve optimal eradication rates. Rifaximin and rifabutin are new antibiotics. The aim of this study was to...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Yong Chan Lee
2020-09-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2020-0021.pdf |